CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
63.13
-0.69 (-1.08%)
At close: Oct 12, 2026, 4:00 PM EDT
63.13
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:10 PM EDT
CG Oncology Revenue
CG Oncology had revenue of $1.16M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $6.23M, up 1,030.31% year-over-year. In the year 2025, CG Oncology had annual revenue of $4.04M with 254.70% growth. That makes CG Oncology the 39,201st largest company in the world by revenue and 5,191st in the United States.
Revenue (ttm)
$6.23M
Revenue Growth
+1,030.31%
P/S Ratio
898.50
Revenue / Employee
$43,859
Employees
142
Market Cap
5.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.04M | 2.90M | 254.70% |
| Dec 31, 2024 | 1.14M | 935.00K | 458.33% |
| Dec 31, 2023 | 204.00K | 13.00K | 6.81% |
| Dec 31, 2022 | 191.00K | -10.17M | -98.16% |
| Dec 31, 2021 | 10.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CGON News
- 17 days ago - CG Oncology Slides: Investor presentation - Filings
- 4 weeks ago - CG Oncology Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - CG Oncology Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - CG Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 2 months ago - CG Oncology price target raised to $85 from $82 at Truist - TheFly
- 2 months ago - CG Oncology price target lowered to $79 from $81 at RBC Capital - TheFly
- 2 months ago - CG Oncology reports Q2 EPS (90c), consensus (64c) - TheFly
- 2 months ago - CG Oncology Earnings release: Q2 2026 - Filings